Filing Impact
Filing Sentiment
Form Type
6-K
Organigram Global Inc
May 27, 2025
Organigram Global Announces CEO Succession Plan
219.57M
90.33M
32.41%
5.81%
4.18%
Drug Manufacturers - Specialty & Generic
Healthcare
Canada
Toronto